Galectin-9 and Tim-3 are upregulated in response to microglial activation induced by the peptide Amyloid-ß (25-35).

Galectins are a group of ß-galactoside-binding lectins associated with regulating immunological response. In the brains of AD patients and 5xFAD (familial AD) mice, galectin-3 (Gal-3) was highly upregulated and found to be expressed in microglia associated with Aß plaques. However, the participation of other galectins, specifically galectin-9 (Gal-9) and T-cell immunoglobulin and mucin domain 3 (Tim-3) receptors, are unknown in the inflammatory response. The experimental model of the Aß25-35 peptide will allow us to study the mechanisms of neuroinflammation and describe the changes in the expression of the Gal-9 and Tim-3 receptor. This study aimed to evaluate whether Aß25-35 peptide administration into the lateral ventricles of rats upregulated Gal-9 and Tim-3 implicated in the modulation of neuroinflammation. The vehicle or Aß25-35 peptide (1 µg/µL) was bilaterally administered into the lateral ventricles of the rat, and control group. After the administration of the Aß25-35 peptide, animals were tested for learning (day 29) and spatial memory (day 30) in the novel object recognition test (NOR). On day 31, hippocampus was examined for morphological changes by Nilss stain, biochemical changes by NO2 and MDA, immunohistochemical analysis by astrocytes (GFAP), microglia (Iba1), Gal-9 and Tim-3, and western blot. Our results show the administration of the Aß25-35 peptide into the lateral ventricles of rats induce memory impairment in the NOR by increases the oxidative stress and inflammatory response. This result is associated with an upregulation of Gal-9 and Tim-3 predominantly detected in the microglia cells of Aß25-35-treated rats with respect to the control group. Gal-9 and Tim-3 are upregulated in activated microglia that could modulate the inflammatory response and damage in neurodegenerative processes induced by the Aß25-35 peptide. Therefore, we suggest that Gal-9 and Tim-3 participate in the inflammatory process induced by the administration of the Aß25-35 peptide.

Estructura y función de la alfa-fetoproteína / Structure and function of the alpha-fetoprotein

Resumen: La alfa-fetoproteína es una glicoproteína que ha sido considerada como un marcador oncofetal, cuya aplicación se ha demostrado en el diagnóstico y pronóstico de enfermedades tumorales como el carcinoma hepatocelular, y también es de gran utilidad para identificar malformaciones fetales relacionadas con fallas del cierre del tubo neural y anencefalia. Diversos trabajos establecen una interesante relación entre la estructura y la función de esta proteína que permite regular la respuesta inmune de la madre y que podría participar en los eventos que evitan el rechazo del embrión. En esta revisión se identifican algunos aspectos moleculares de la alfa-fetoproteína que abren interesantes perspectivas para entender mejor su participación en el desarrollo de alteraciones tumorales.

Abstract: Alpha-fetoprotein is a glycoprotein that has been considered an oncofetal marker and demonstrated its application in tumor diagnosis and prognosis of diseases such as hepatocellular carcinoma, is also useful to identify fetal malformations related to failure of neural tube closure and anencephaly. There are several works that make an interesting relationship between the structure and function of this protein that allows it to regulate the immune response of the mother and could participate in events that prevent rejection of the embryo. In this review some molecular aspects of alpha-fetoprotein that open interesting perspectives to better understand their participation in the development of tumor abnormalities are identified.

Inmunolocalización del complejo polisacárido-proteína en ultraestructuras de la fase micelial y levaduriforme de Histoplasma capsulatum / Immunolocalization of the polysaccharide-protein complex (PPCD-Histo) in the Histoplasma capsulatum mycelium and yeast phase ultrastructures

Introducción: El empleo de un antígeno parcialmente purificado denominado complejo polisacárido-proteína desproinizado de Histoplasma capsulatum (CPPD-Histo), utilizado para discriminar la histoplasmosis de diversas micosis pulmonares y otras enfermedades respiratorias en métodos inmunodiagnósticos de alta sensibilidad, ha sido motivo de estudio desde hace años por nuestro grupo de investigación: Objetivo: En este trabajo se planteó conocer la ubicación celular preferencial del antígeno CPPD-Histo, en las diferentes formas y estructuras de las fases micelial y levaduriforme del hongo. Material y métodos: El estudio se desarrolló mediante inmunolocalización con marcaje de oro coloidal para microscopia electrónica, usando anticuerpos primarios CPPD-Histo específicos. Resultados y discusión: La localización en microscopia electrónica mostró mayor concentración del CPPD-Histo en las zonas de mayor grosor de la capa externa de la pared celular de las proyecciones digitiformes de macroconidios, poco marcaje en pared celular de hifas, y una distribución dispersa de la marca en las levaduras. Conclusión: La pared celular de los macroconidios de la fase micelial del hongo es la estructura fúngica con mayor concentración del antígeno CPPD-Histo